Home>News Center>China
       
 

Roche licenses China firm to produce Tamiflu
(AP/Xinhua)
Updated: 2005-12-12 19:57

Swiss drugmaker Roche Holding AG said Monday it has chosen 12 potential partners for the production of Tamiflu and granted one sublicense for the antiviral drug to Shanghai Pharmaceutical.

Roche licenses China firm to produce Tamiflu
The Swiss pharmaceutical giant Roche said it had reached a sublicensing deal for production of its flagship anti-influenza drug Tamiflu in China with Shanghai Pharmaceutical group. [AFP]

Roche said it will grant Shanghai Pharmaceutical rights for the overall production of Tamiflu, also known as oseltamivir, for use in China.

"They are allowed to and they will produce the drug from the beginning to the end," said Piller.

Shanghai Pharmaceutical Group also announced the licensing agreement Monday at its website Monday, saying "Roche and Shanghai Pharmaceutical Group have signed the first sub-licensing agreement for the overall production of oseltamivir for pandemic use in China."

An official with the Shanghai Pharmaceutical Group said its products will not bear the name of "Tamiflu", but the ingredients and quality will be the same with Tamiflu produced by Roche.

He said the group aims to form a monthly production capacity of 200,000 treatments in six months in the first step.

According to the official, the group made the request to produce and sell Tamiflu under a sub-license in November.

The announcement said Roche is also "in negotiations for local partnerships in other countries."

Roche said it compiled the shortlist of potential partners, which it did not identify, after evaluating around 200 applicants interested in helping with certain steps in the manufacture of Tamiflu. It didn't say how many it would finally choose.

Roche said it would mainly use the partners, which include major pharmaceutical makers, large generic manufacturers and specialty chemical producers, as backups, to meet specific regional needs and to prepare for any large additional government orders in the future.

"We are now also in the position to have a backup supply in case of an emergency," said David Reddy, who heads Roche's influenza pandemic task force.

   上一頁 1 2 下一頁  



Fire kills 5 in Northeast China
Aerobatics show in Hunan
Final rehearsal
  Today's Top News     Top China News
 

Australia, US, Japan praise China for Asia engagement

 

   
 

Banker: China doing its best on flexible yuan

 

   
 

Hopes high for oil pipeline deal

 

   
 

Possibilities of bird flu outbreaks reduced

 

   
 

Milosevic buried after emotional farewell

 

   
 

China considers trade contracts in India

 

   
  EU likely to impose tax on imports of Chinese shoes
   
  Bankers confident about future growth
   
  Curtain to be raised on Year of Russia
   
  Coal output set to reach record high of 2.5b tons
   
  WTO: China should reconsider currency plan
   
  China: Military buildup 'transparent'
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Roche sets up R&D centre in Shanghai
   
Roche to expand presence in China
   
China human bird flu vaccine at least a year away
   
China: Bird flu virus in humans mutating
   
Study: Vaccine can stop poultry from spreading bird flu to each other
   
China confirms fifth human case of bird flu
   
Human case confirmed in Liaoning
   
Roche in talks for Tamiflu production in China
Manufacturers, Exporters, Wholesalers - Global trade starts here.
Advertisement
         
主站蜘蛛池模板: 亚洲乱码在线视频| 四虎影视在线观看永久地址| 99久久国产热无码精品免费 | 日本尤物精品视频在线看| 国模精品一区二区三区| 一个人看的日本www| 成都4片p高清视频| 久久久亚洲欧洲日产国码农村| 最近中文字幕高清中文字幕电影二| 亚洲男人的天堂在线播放| 男女一进一出无遮挡黄| 又黄又爽又色的视频| 草莓app在线观看| 国产女人高潮视频在线观看| 亚洲武侠欧美自拍校园| 国产精品原创巨作av| 91caoprom| 国内精品人妻无码久久久影院导航 | 国产大片线上免费看| 天天成人综合网| 国产精品免费大片| 5060午夜一级一片| 国模gogo大胆高清网站女模| japonensis19一20刚开始的| 强开小婷嫩苞又嫩又紧视频韩国 | 中文字幕在线播放第一页| 日本护士xxxx视频| 久久的精品99精品66| 日韩精品专区在线影院重磅| 亚洲AV无码乱码麻豆精品国产| 欧美亚洲国产成人高清在线| 亚洲国产夜色在线观看| 欧美性猛交xxxx乱大交| 亚洲成aⅴ人片| 欧美日本精品一区二区三区| 亚洲欧美一级久久精品| 欧美特黄一免在线观看| 亚洲日韩中文字幕一区| 欧美日韩亚洲国产精品| 亚洲国产精品无码久久青草| 欧美日本视频在线观看|